|
SERUM FERRITIN LEVEL AS A PREDICTOR OF RESPONSE TO PEGYLATED INTERFERON / RIBAVIRIN THERAPY IN EGYPTIAN CHRONIC
HEPATITIS C PATIENTS
|
|
CHANGES IN BLOOD GLUCOSE LEVELS IN CHRONIC HEPATITIS C EGYPTIAN PATIENTS TREATED WITH ANTIVIRAL THERAPY AND ITS IMPACT ON VIROLOGICAL RESPONSE
|
|
NONINVASIVE DETECTION OF HEPATIC FIBROSIS IN EGYPTIAN CHRONIC HEPATITIS C PATIENTS
|
|
The Effect of Liver Cirrhosis Severity on Left Ventricular Systolic and Diastolic Functions
|
|
Evaluation of Transient Elastography in Diagnosis of Esophageal Vances in Chronic. Hepatitis C Patients
|
|
Mean platelet Volume and Hepatic Stellate Cells Activity as Fibrosis Markers in Egyptian Patients with Chronic Hepatitis C
|
|
Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma
|
|
Significance of Antinuclear Antibody Positivity in Chronic HCV Patients and Impact on Early Response to Combined Antiviral Therapy
|
|
interleukin-10 as a predictor of response to interferon therapy in egyptian patients with chronic hepatitis C virus infection
|
|
Interplay Between Tumor Necrosis Factor-α, Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Hepatitis C Egyptian Patients
|
|
Monocyte Chemotactic protein-1 gene expression in blood and ascitic fluid of cirrhotic patients with spontaneous bactrial peritonitis
|
|
Evaluation of Response to Sofosbuvir based treatment Regimens in Chronic HCV patients
|
|
A Retrospective Comparative Study of post Living Donor Liver Transplanation between Cirrhotic Patients with and without Hepatocellular Carcinoma
|
|
Study of the Helcobacter pylori infection in chronic obstructive pulmonary disease
|
|
Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt
|
|
Impact of Heliobacter pylori eradication on absolute telomere length in gastric mucosa
|
|
Evaluation of Serum autotaxin as a novel noninvasive marker for assessment of hepatic fibrosis in chronic hepatitis C patientst
|
|
Mean Platelet Volume and Mean Platelet Volume/Platelet Count
Ratio as Diagnostic Markers for Hepatocellular Carcinoma in
Chronic Hepatitis C Patients
|
|
Assessment of Alpha-1-Acid Glycoprotein as a new Biomarker for
Hepatocellular Carcinoma
|
|
Assessment of liver fibrosis in Egyptian chronic
hepatitis B patients
|
|
Serum human endothelial cell-specific molecule-1
(endocan) and vascular endothelial growth factor
in cirrhotic HCV patients with hepatocellular
carcinoma as predictors of mortality
|
|
Serum human endothelial cell-specific molecule-1
(endocan) and vascular endothelial growth factor
in cirrhotic HCV patients with hepatocellular
carcinoma as predictors of mortality
|
|
Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy
|
|
Monocyte Chemotactic Protein-1 Gene Expression in Blood and
Ascitic Fluid of Cirrhotic Patients with Spontaneous Bacterial
Peritonitis
|
|
Serum human endothelial cell-specific molecule-1 (Endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality
|
|
Diagnostic Significance of Serum Serotonin Levels in Prediction of
Esophageal and Fundal Varices in Cirrhotic Patients
|
|
Assessment of Alpha-1-Acid Glycoprotein as a new Biomarker for
Hepatocellular Carcinoma
|
|
Evaluation of Serum Autotaxin as a Novel Noninvasive Marker for
Assessment of Hepatic Fibrosis in Chronic Hepatitis C Patients
|
|
Mean Platelet Volume and Mean Platelet Volume/Platelet Count
Ratio as Diagnostic Markers for Hepatocellular Carcinoma in
Chronic Hepatitis C Patients
|
|
Clinical Significance of Serum Midkine Level as a Biomarker in
Diagnosis of Hepatocellular Carcinoma
|
|
Evaluation of Transforming Growth Factor- β 1 Gene Expression
and Polymorphism in Diagnosis of Hepatocellular Carcinoma in
HCV-Infected Patients
|